Have Questions? Call Us Toll Free (877) 880-5251

News

Johns Hopkins University School of Medicine researchers studied the ocular as well as systemic effects that three anti-VEGF therapies had on patients. Pegatanib, ranibizumab and bevacizumab were all compared to p
Researchers at the University of California - Berkeley have found a way to treat eye diseases such as macular degeneration by turning ganglion cells into cells that can sense light. Many degenerative eye diseases are caused by photoreceptors that no longer work correct
A study that involved a revolutionary treatment using stem cells from the eyes of non-living donors is detailed in STEM CELLS Translational Medicine.Researchers hope that
Google is pairing up with it's sister company, Verily, to make screening for diabetic retinopathy and diabetic edema more accessible for patients in India.India faces a shortage of more than 100,000 eye doctors and an epidemic of diabetic retinopathy.
A surgeon at the John Radc
In an effort to determine whether preoperative (pre-op) phone calls could safely be a substitute for the traditional in-person pre-op office visit, researchers conducted a retrospective study of the outcomes of pre-op phone consults and traditional in-person pre-op offic
A new company, Precis
One month ago, a 52 year-old woman came into my office with the sole complaint that she struggled to see at night. Her vision measured 20/20, and she had no catarac
There are many
Organizations touting
While cataracts
Fo
A new blood test is being developed by Australian researchers at The John Curtin School of Medical Research that detects whether a patient is at risk of developing dry age
Charles Bonnet Syndrome (CBS) is a condition that age-related macular degeneration patients can develop that causes visual hallucinations. It is found in patients who have profound vision loss.
Should a patient undergoing cataract surgery
Humans deve
The cart
For your family members without macular degeneration who want
The United States Patent and Trademark Office has g
VisiVite's two lutein eye supplements can be taken with your AREDS 2 regimen, or on their own.
You might t
Trust in the company, plus a wide Choice in Eye Formulas, Natural Ingredients, and Automatic Delivery make VisiVite popular among doctors and customers. See the results of the three survey questions below. Of the more than 300 responses in VisiVite Eye Vitamins survey, two-thirds use on
Of the more than 300 responses in a recent survey, "Trust in Company" was the most important reason that customers buy VisiVite Eye Vitamins for their eye health. The rest of the list would make any supplement manufacturer so proud they would blush: Wide Choice in Eye Formulas, Natural Ing
Of the more than 300 responses in VisiVite Eye Vitamins survey, two-thirds use one of VisiVIte's four AREDS 2 formulas, with VisiVite AREDS 2 PLUS+ Gold being the #1 choice. VisiVite Super Lutein 444,
Of the more than 300 responses in VisiVite Eye Vitamins survey, nearly two-thirds use them because they have a diagnosis of Macular Degeneration, a potentially blinding eye disease more likely to occur as people age. Rounding out the list as reasons p
One of the benefits of formulating macular degeneration supplements and being an eye physician who examines patients is that you can experience the fruits of your sleepless nights fretting about choosing the best natural ingredients that are based upon the latest scientific research. And s
Green and red lasers that carry low power and are used for presentation pointers can cause retinal burns if the ey
Most of the world's trans-resveratrol nutrition supply is sou

Search VisiVite